ClinicalTrials.Veeva

Menu

rTMS-enhanced Psychotherapy for Borderline Personality Disorder (rTMS-DBT)

M

Masarykova Univerzita

Status

Active, not recruiting

Conditions

Borderline Personality Disorder

Treatments

Device: Prefrontal rTMS treatment
Behavioral: Dialectical behavioral therapy program
Device: Sham rTMS sessions

Study type

Interventional

Funder types

Other

Identifiers

NCT06259851
NU23-04-00472

Details and patient eligibility

About

This project assesses the effectiveness and lasting impact of combining Dialectical Behavioral Therapy (DBT) with prefrontal repetitive transcranial magnetic stimulation (rTMS) in patients with borderline personality disorder.

Full description

The proposed project aims to evaluate the effectiveness of combining Dialectical Behavioral Therapy (DBT) with prefrontal repetitive transcranial magnetic stimulation (rTMS) in individuals with borderline personality disorder (BPD). The study includes four groups of patients: 1) DBT combined with active prefrontal rTMS treatment (rTMS-DBT group), 2) DBT combined with sham rTMS treatment (sham-DBT group), 3) active prefrontal rTMS treatment only (rTMS-only group), and 4) sham rTMS treatment only (sham-only group). The study will include assessments conducted before (T1) and after the rTMS treatment (T2) composed of self-reported questionnaires, clinical interviews assessing self-harming behavior and healthcare utilization, ecological momentary assessment of emotional variability, functional magnetic resonance imaging (fMRI) during emotional task, and control clinical EEG measurements. Follow-up measurements will be conducted at T3 (three months after rTMS), and for DBT group also at T4 (six months after rTMS), and T5 (twelve months after rTMS) for to track long-term effects.

Enrollment

60 estimated patients

Sex

Female

Ages

16+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • diagnosis of borderline personality disorder according to Diagnostic and Statistical Manual 5th Edition (DSM-5) criteria (rated by Structured Clinical Interview for DSM-5 for Personality Disorders, BPD section)
  • minimum age 16, informed consent of the patient
  • informed consent of patient's legal representative in case of patients under age 18

Exclusion criteria

  • neurological disorder
  • comorbid affective disorder or schizophrenia-related disorder
  • intelligence quotient<70
  • contraindications for MRI measurement
  • contraindication for rTMS treatment
  • pregnancy

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Factorial Assignment

Masking

Double Blind

60 participants in 4 patient groups

rTMS-DBT group
Experimental group
Description:
Patients receiving combined DBT and active prefrontal rTMS treatment
Treatment:
Behavioral: Dialectical behavioral therapy program
Device: Prefrontal rTMS treatment
Sham-DBT group
Active Comparator group
Description:
Patients receiving combined DBT and sham rTMS treatment
Treatment:
Device: Sham rTMS sessions
Behavioral: Dialectical behavioral therapy program
rTMS-only group
Active Comparator group
Description:
Patients receiving only active prefrontal rTMS treatment
Treatment:
Device: Prefrontal rTMS treatment
sham-only group
Sham Comparator group
Description:
Patients receiving only sham rTMS treatment
Treatment:
Device: Sham rTMS sessions

Trial contacts and locations

1

Loading...

Central trial contact

Pavla Linhartová, Ph.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems